Skip to main content
. 2015 Nov 4;2015(11):CD010794. doi: 10.1002/14651858.CD010794.pub2
Drug Dose (mg) Number of Number with outcome/total Percent with outcome Risk ratio
 (95% CI) NNT
 (95% CI)
Studies Participants Active Placebo Active Placebo
Aspirin 500 2 213 45/135 20/78 34 26 1.3 (0.8 to 2.0) Not calculated
Aspirin 600/650 60 4965 983/2496 379/2469 39 15 2.5 (2.3 to 2.8) 4.2 (3.8 to 4.6)
Aspirin 1000 6 618 138/340 40/278 41 14 2.7 (2.0 to 3.7) 4.2 (3.8 to 4.6)
Dexketoprofen 12.5 5 452 104/230 38/222 45 17 2.7 (2.0 to 3.7) 3.6 (2.8 to 5.0)
Dexketoprofen 25 6 523 129/225 38/248 47 15 3.3 (2.4 to 4.5) 3.2 (2.6 to 4.1)
Diclofenac potassium 25 4 502 140/248 37/274 56 15 3.9 (2.8 to 5.3) 2.4 (2.0 to 2.9)
Diclofenac potassium 50 7 757 253/398 60/359 64 17 3.7 (2.9 to 4.7) 2.1 (1.9 to 2.5)
Dipyrone 500 5 288 106/143 45/145 74 31 2.4 (1.8 to 3.1) 2.3 (1.9 to 3.1)
Ibuprofen acid 200 18 2103 448/1094 67/1009 41 7 6.5 (5.1 to 8.2) 2.9 (2.7 to 3.2)
Ibuprofen acid 400 51 5604 1596/3070 289/2543 52 12 4.6 (4.0 to 5.1) 2.5 (2.4 to 2.6)
Ibuprofen fast acting 200 7 828 270/478 34/350 57 10 5.7 (4.2 to 7.9) 2.1 (1.9 to 2.4)
Ibuprofen fast acting 400 13 1364 427/658 85/466 65 18 3.9 (3.2 to 4.7) 2.1 (1.9 to 2.3)
Ibuprofen + caffeine 200+100 4 334 103/174 16/160 59 10 5.5 (3.5 to 8.7) 2.1 (1.9 to 3.1)
Ibuprofen + paracetamol 200+500 3 508 240/349 10/159 69 6 10 (5.7 to 19) 1.6 (1.5 to 1.8)
Ibuprofen + paracetamol 400+1000 3 543 278/384 10/159 72 6 11 (6.2 to 20) 1.5 (1.4 to 1.7)
Naproxen 200/220 2 202 54/120 16/82 45 30 2.9 (1.6 to 5.1) 3.4 (2.4 to 5.8)
Naproxen 400/440 3 334 103/210 14/124 49 11 4.8 (2.8 to 8.4) 2.7 (2.2 to 3.5)
Naproxen 500/550 9 784 200/394 59/390 52 15 3.4 (2.6 to 4.4) 2.7 (2.3 to 3.3)
Paracetamol 500 6 561 176/290 86/271 61 32 1.9 (1.6 to 2.3) 3.5 (2.7 to 4.8)
Paracetamol 600/650 19 1886 358/954 145/932 38 16 2.4 (2.0 to 2.8) 4.6 (3.9 to 5.5)
Paracetamol 975/1000 28 3232 876/1906 241/1329 46 18 2.7 (2.4 to 3.0) 3.6 (3.2 to 4.1)
CI: confidence interval; NNT: number needed to treat for an additional beneficial outcome.
Note: NNT not calculated when result not significantly different from placebo.